The Venture Codex Logo

The Venture Codex

Sunflower Capital

50 Osgood Place Suite 400, San Francisco, CA, 94133, United States

Overview

Sunflower Capital is a venture capital firm specializing in seed stage and early stage investments.

Total investments
18
Lead investments
2
Investments · 12mo
11
Active investors
0

Sector focus

  • Venture Capital
Visit website

Investment portfolio

  • Atlas Motion

    Participated · Seed · Aug 2026

    Atlas Motion designs and develops specialized Brushless DC (BLDC) motors and high-power-density actuators engineered for defense platforms. The company prototypes and designs hardware in Long Beach and mass-produces systems out of a facility in the Philippines. After emerging from stealth, Atlas Motion raised $11.5M to support manufacturing expansion and operational growth. Planned uses of the capital include opening a second manufacturing plant in the Philippines, building its “Vector” AI production line orchestration software, expanding headcount to roughly 60 employees, and establishing a dedicated U.S. facility to serve domestic defense customers. The business was founded and is led by co-founders Christian Mochen (CEO), Tom Baron, and Carlo Dela Rosa (COO).

  • SONATA

    Led · Seed · Jul 2026

    Sonata develops a doctor-led longevity healthcare membership that integrates whole-genome sequencing, DNA methylation analysis, over 140 blood biomarkers, and real-time wearable telemetry into a single longitudinal wellness record. The company charges a direct-to-consumer $2,500 annual founding membership fee, which is eligible for HSA/FSA funds. Led by CEO Sagan Schultz, Sonata plans to expand its proprietary clinical AI platform and scale physician-led digital care networks. It intends to accelerate consumer membership onboarding across launch hubs in New York, San Francisco, and Los Angeles. The company emerged from stealth concurrent with announcing its $7M seed financing.

  • Singularity Defense

    Participated · Series A · Jul 2026

    Singularity Defense develops air-defense and counter-weapon systems designed to defeat proliferating low-cost drones and munitions. The company emphasizes rapid iterative testing and vertical integration to deliver capabilities at the speed, scale, and cost the threat demands. Its leadership includes founders Jack Oswald and shail giroux and a team with engineers from SpaceX, Tesla and Anduril alongside operators who have frontline experience. Singularity emerged from stealth concurrent with an oversubscribed $80 million Series A announced by AE Ventures. The company frames its mission around protecting people on the battlefield and at home and is positioning to scale development and deployment rapidly. Public communications highlight urgency and a focus on engineering counter-weapon systems at scale.

  • Podium Automation

    Participated · Series A · Jun 2026

    Podium Automation builds and ships UL 508A certified industrial control panels using a software-driven end-to-end design and manufacturing process. Its proprietary software connects customer requirements, eCAD design tools, and shop floor instructions to automate component selection and generate validated assembly instructions. The company says it can design and deliver panels in less than four weeks versus legacy lead times that often exceed 12 weeks. Podium emphasizes manufacturability and component availability to reduce errors and speed delivery, serving customers from scale-ups to Fortune 500 manufacturers. It operates a UL 508A certified facility and plans to expand manufacturing capacity and grow engineering and operations teams. Podium was founded in 2024 and is headquartered in Brooklyn, New York; it has raised $18 million in Series A funding, bringing total capital raised to over $23 million.

  • Adaptive Innovations

    Participated · Series A · Jun 2026

    Adaptive Innovations builds an AI-native operating system and clinical services platform for home healthcare that automates medical intake, scheduling, charting, compliance, and billing. The company reports it has delivered over 100,000 patient visits across Texas hospital networks and has reduced clinical rehospitalization rates to 4.9 percent. It also says practitioner documentation timelines have been reduced by roughly 80 percent. Leadership is led by Co-CEOs Alex Wendland and Logan Stinson, CTO Ryan Tolsma, and COO Hunter Stinson. Financially, the company has raised $60M to date, including the recent $50M Series A. Planned uses of the new capital include expanding engineering and operations headcount, accelerating software development, and entering new state markets.

Team

No current team members are available.